SCHEMBL9921422

SCHEMBL9921422

Fc1cnc2ncnc(NCCc3ccc(C(F)(F)F)cc3)c2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 7/20 0.50
▸ EGFR P00533 2/20 0.46
▸ PDE2A O00408 1/20 0.43
▸ SLC29A1 Q99808 1/20 0.43
▸ AURKA O14965 4/20 0.42
▸ AURKB Q96GD4 3/20 0.42
▸ LMNA P02545 2/20 0.40
▸ APP P05067 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ NTRK1 P04629 2/20 0.40
▸ POLB P06746 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ NR2F2 P24468 1/20 0.40
▸ TTBK1 Q5TCY1 2/20 0.39
▸ TTBK2 Q6IQ55 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ RPS6KB1 P23443 1/20 0.39
▸ CNR1 P21554 1/20 0.39
▸ CCNC P24863 1/20 0.39
▸ CDK8 P49336 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9921333 0.87 HTT (0.53) HTTEGFRPDE2ASLC29A1AURKA
SCHEMBL9921444 0.87 EGFR (0.45) HTTEGFRPDE2ASLC29A1AURKA
SCHEMBL9921325 0.85 HTT (0.55) HTTEGFRSLC29A1LMNAAPP
SCHEMBL9921335 0.85 HTT (0.60) HTTEGFRSLC29A1LMNAAPP
SCHEMBL9921323 0.85 HTT (0.52) HTTEGFRSLC29A1LMNAAPP
SCHEMBL9921329 0.85 HTT (0.38) HTTEGFRSLC29A1AURKAAURKB
SCHEMBL9921423 0.85 HTT (0.47) HTTEGFRSLC29A1LMNAAPP
SCHEMBL9921338 0.85 PDE2A (0.45) HTTEGFRPDE2AAURKAAURKB
SCHEMBL9921324 0.83 PDE2A (0.44) HTTEGFRPDE2AAURKAAURKB
SCHEMBL9921332 0.83 PDE2A (0.47) HTTEGFRPDE2AAURKAAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY (CN) 2012-10-11 — — US disclosed
WO-2012079079-A1 PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-06-14 — — WO disclosed
WO-2011011522-A2 POTENT SMALL MOLECULE INHIBITORS OF AUTOPHAGY, AND METHODS OF USE THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-01-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120258975-A1 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof ATG7, BECN1, SQSTM1 HTT 4078/4885EGFR 2099/4885PDE2A 3240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback